Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loophole
“Biotech industry leaders must forge a new geographic path before heavy-handed legislation forces the issue,” write…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 703 articles · page 15 of 20 · fetched 38 minutes ago
Opinion: I studied Reddit forums on menopause — and found what doctors are missing
“The menopause symptoms women are discussing online should become the questions researchers ask next,” writes…
Read at source →
Kennedy posts vaccine misinformation, spars on social media amid measles deaths
Kennedy has blamed others for declining vaccination rates, and downplayed the dangers of measles.
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
On the fence about a statin? In borderline cases, calcium scans could be a tiebreaker
The increasingly popular coronary artery calcium scan is helpful in guiding statin use in only a small share of cases,…
Read at source →
STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a…
Read at source →
STAT+: Key data on a new class of cardio drugs are coming
GSK's shingles vaccine, new financial investment in women's health, and more biotech news from The Readout
Read at source →
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in…
Read at source →
Even at big companies, health care costs are increasing
Two U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news today
Read at source →
STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more
About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see…
Read at source →
Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows…
Read at source →
STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot.…
Read at source →
STAT+: When it comes to women’s health, money talks
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments,…
Read at source →
Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of…
Read at source →
Opinion: Medical aid in dying and the burden of choosing to live
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.
Read at source →
STAT+: Sword Health to acquire Headspace, according to filing
Sword Health, a digital health company, plans to acquire mental health services provider Headspace, according to a…
Read at source →
Pennsylvania reports first 2 measles deaths in the U.S. this year, both people unvaccinated
Two unvaccinated Pennsylvania residents have died from measles, state health officials said Tuesday, the first…
Read at source →
STAT+: How Trump’s funding cuts are reshaping the health system
STAT examines Republicans’ health care funding cuts, mRNA science defeats politics, and Medicaid tries out a new way to…
Read at source →
STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002.…
Read at source →
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
In this edition of STAT Health Tech: FDA's plans for regulating generative AI-powered devices, and updates from EPIC's…
Read at source →
STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
Turkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging…
Read at source →STAT+: Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation…
Read at source →
CDC releases latest life expectancy data
Deleted public comments on White House proposals, how Trump cuts are reshaping rural health care, and more Morning…
Read at source →
STAT+: Comments on OMB research rule mysteriously removed from federal website
Some comments on a proposed OMB research rule have been mysteriously removed from a public-facing government webpage.
Read at source →
STAT+: AI is good at catching drug theft at hospitals, but only when humans do their part
New AI technology can help hospitals prevent controlled substances from being stolen, or abused by staff, but those…
Read at source →
Opinion: Whale songs: the sounds of love and loss as heard by an OB-GYN
“I have developed a trained ear for many kinds of ‘humanized’ whale songs especially the types sung by women,” writes…
Read at source →
Opinion: Cancer screening guidelines need to address long-term care facilities
After her aunt died, cancer epidemiologist Kim Johnson looked into screening guidelines for long-term care residents —…
Read at source →
How Trump’s cuts are reshaping America’s health system
A scramble to prepare for massive federal cuts across the health care system is hitting rural states like Maine…
Read at source →
STAT+: Lady Gaga and her fiancé launch a biotech startup
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more…
Read at source →
STAT+: Public-sector purgatory, and a union-hospital fight
Aon, the big consulting and brokerage house, confirms 2027 is going to be brutal for job-based health care premiums.…
Read at source →STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is…
Read at source →
FDA plans to regulate generative AI
New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds
Read at source →
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
Read at source →
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges,…
Read at source →
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
The legal theory used to restrict gender-affirming care for minors could be applied broadly, experts say.
Read at source →
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s…
Read at source →
Nurse practitioner trainees find themselves stymied by shortage of clinical mentors
Nurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.
Read at source →